XEN-801
/ Xenon
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
June 28, 2017
A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel
(clinicaltrials.gov)
- P1/2; N=213; Completed; Sponsor: Xenon Pharmaceuticals Inc.; Active, not recruiting ➔ Completed
Trial completion • Biosimilar • Immunology
November 08, 2016
A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel
(clinicaltrials.gov)
- P1/2; N=198; Active, not recruiting; Sponsor: Xenon Pharmaceuticals Inc.; Recruiting ➔ Active, not recruiting
Enrollment closed • Biosimilar • Immunology
September 01, 2016
A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel
(clinicaltrials.gov)
- P1/2; N=198; Recruiting; Sponsor: Xenon Pharmaceuticals Inc.; Trial primary completion date: Oct 2016 ➔ Mar 2017
Trial primary completion date • Biosimilar • Immunology
1 to 3
Of
3
Go to page
1